Cargando…
Formulation development and investigation of domperidone transdermal patches
AIM AND BACKGROUND: Domperidone is a dopamine antagonist with antiemetic properties having a plasma half life of 7-9 h with 15% oral bioavailability. In the present work transdermal patches of domperidone were prepared with the objective to improve its therapeutic efficacy, patient compliance and to...
Autores principales: | Prabhu, Prabhakar, Shah, Samip, Gundad, Shankar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465151/ https://www.ncbi.nlm.nih.gov/pubmed/23071950 http://dx.doi.org/10.4103/2230-973X.93008 |
Ejemplares similares
-
Development of domperidone bilayered matrix type transdermal patches: physicochemical, in vitro and ex vivo characterization
por: Madishetti, S.K., et al.
Publicado: (2010) -
Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011) -
Formulation development and evaluation of mouth dissolving film of domperidone
por: Joshi, Pratikkumar, et al.
Publicado: (2012) -
Formulation Design and Development of a Unani Transdermal Patch for Antiemetic Therapy and Its Pharmaceutical Evaluation
por: Saleem, Mohd Nauman, et al.
Publicado: (2016) -
Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine
por: Lei, Yaran, et al.
Publicado: (2022)